Overview
- 23 inspections across 21 sites are on record.
- 90 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-13.
At a glance
Inspections
23
Sites
21
Observations
90
Career since
Apr 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Acella Pharmaceuticals, LLC | 13 Apr 2026 | Human Drugs | |
| Alora Pharmaceuticals | 13 Apr 2026 | Human Drugs | On file |
| PETNET Solutions, Inc. | 2 Mar 2026 | Human Drugs | On file |
| Greer Laboratories, Inc. | 12 Dec 2025 | Human Drugs | On file |
| Sterling Contract Packaging Inc | 31 Oct 2025 | Human Drugs |
Sites inspected
Acella Pharmaceuticals, LLCAlpharetta, United States1 insp.
Alora PharmaceuticalsAlpharetta, United States1 insp.
PETNET Solutions, Inc.Atlanta, United States1 insp.
Greer Laboratories, Inc.Lenoir, United States1 insp.
Sterling Contract Packaging IncMoore, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Veronica Fuentes8 shared
Jared P Stevens3 shared
Inga M Warr3 shared
Pratik S Upadhyay2 shared
Tamil Arasu2 shared
J'Maica J Hunter2 shared
Tomika L Crafter1 shared
Andrew O Ejiofor1 shared
Mabany Lizardi1 shared
Alan A Rivera1 shared
Full investigator report
Get the verbatim findings behind Samantha E Cleek's 90 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site